Mark Mossler insider trades

Open-market stock purchases and sales by Mark Mossler, Chief Accounting Officer at C4 Therapeutics, Inc, from SEC Form 4 filings since Feb 14, 2024.

Recent trades

DateStockTradeValue
Feb 14, 2026CCCC C4 Therapeutics, IncBought (not open market)—
Feb 14, 2026CCCC C4 Therapeutics, IncSold (not open market)$6.2K
Feb 13, 2026CCCC C4 Therapeutics, IncBought (not open market)—

Companies traded

  • CCCC C4 Therapeutics, Inc: other filings, last Feb 14, 2026

Get free alerts when Mark Mossler files a new trade →